Essentials of Genetics (9th Edition) - Standalone book
Essentials of Genetics (9th Edition) - Standalone book
9th Edition
ISBN: 9780134047799
Author: William S. Klug, Michael R. Cummings, Charlotte A. Spencer, Michael A. Palladino
Publisher: PEARSON
bartleby

Videos

Textbook Question
Book Icon
Chapter 10, Problem 1CS

A researcher was asked if his work on human telomere replication was related to any genetic disorders. He replied that one might think that any such mutations would be lethal during early development, but in fact a rare human genetic disorder affecting telomeres is known. This disorder, dyskeratosiscongenita (DKC), is associated with mutations in the protein subunits of telomerase, the enzyme responsible for replicating the ends of eukaryotic chromosomes. Initial symptoms appear in tissues derived from rapidly dividing cells, including the skin, nails, and bone marrow, and first affect children between the ages of 5 and 15 years.

How could such individuals survive?

Expert Solution & Answer
Check Mark
Summary Introduction

To review:

The survivability of people with Dyskeratosis congenita (DKC).

Introduction:

Dyskeratosis congenital (DKC) is a rare genetic X chromosome-linked disease. Initial symptoms of this disease show up between the age of 5 to 15 years. People with DKC has the mutation on telomerase gene thus has non-functional telomerase. This disease affects the tissues with rapidly growing cells like skin, nails, and bone marrow.

Explanation of Solution

The tail region of the eukaryotic chromosome is known as the telomere. This region does not contain any functional genes but only guanine and a cytosine-rich tandem repeat of nucleotides. DNA (deoxyribonucleic acid) polymerase responsible for DNA replication cannot replicate the telomere region efficiently. Thus telomerase play a crucial role in replication of telomere. Here in case of persons withDyskeratosis congenita (DKC), after every successful cell division, a part of the telomere region gets lost in the newly divided cell. This problem is known as end replication problem.

The eukaryotic cells use telomerase to replicate telomere, which can successfully replicate the telomere region without losing any of its regions. The whole telomere region of the people with non-functional telomerase gets lost after a few early cell division. However, as this telomere region does not has any functional genes that could affect the cell functionality, early cell divisions can occur smoothly.

The patients can survive early development. Once the whole telomere region gets lost and functional genes present near the telomere region starts getting lost due to further cell division, only then, the patients show symptoms of DKC. That occursnormally between 5- 15 years of age.

Conclusion

Dyskeratosis congenita (DKC) appears among people who have mutated loss-in-function telomerase. Therefore, it can be concluded that the people with non-functional telomerase can survive early development. After that, they will start showing symptoms ofDKC, which includes nail dystrophy, abnormal skin pigmentation, and bone marrow failure.

Want to see more full solutions like this?

Subscribe now to access step-by-step solutions to millions of textbook problems written by subject matter experts!
Students have asked these similar questions
Which of the followings statements are true about DNA polymerase? 1.) It can only go in one direction, meaning the lagging strand can't be synthesized continuously. 2.) It cannot start a DNA strand from scratch, so another enzyme is needed to create "primers" as a starting point. 3.) It cannot copy epigenetic marks (such as methyl groups) on its own; these must be "copied" onto the daughter DNA strand by other enzymes after DNA replication. 4.) All of the above
Scientists identify a tumor cell in rats that divides more rapidly in the presence of galactose. When they sequence the DNA of the tumor cells, they identify retroviral DNA. Explain what circumstances might have occurred that produced this phenotype.
Scientists are working to develop gene therapy to treat Batten disease, also known as Late Infantile Neuronal Ceroid Lipofuscinosis  (LINCL). This fatal, autosomal recessive neurodegenerative disorder results from a mutation in the gene that codes for the enzyme TPP1 (Tripeptidyl peptidase 1).   In the absence of this enzyme, a substance called ceroid lipofuscin accumulates in lysosomes in the brain, resulting in seizures, blindness, decline in cognitive function and motor skills, dementia, and death by the late teens or early 20’s. The TPP1 gene is 6695 bp in length. Think about the characteristics of Batten disease, and then suggest an approach to gene therapy that might be effective for this specific genetic disorder.  You may assume that your research team is working in the U.S. and your research is funded by a grant from the National Institutes of Health (NIH).   1. Briefly outline a procedure that you could use to carry out the gene therapy for Batten disease.
Knowledge Booster
Background pattern image
Biology
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.
Similar questions
SEE MORE QUESTIONS
Recommended textbooks for you
Text book image
Human Heredity: Principles and Issues (MindTap Co...
Biology
ISBN:9781305251052
Author:Michael Cummings
Publisher:Cengage Learning
What are Mutations and what are the different types of Mutations?; Author: Science ABC;https://www.youtube.com/watch?v=I16YlE8qTBU;License: Standard youtube license